IP Library Granted Patent US 9,956,251
Granted Patent B2
US 9,956,251 · App. 14/901,635 · Granted May 1, 2018

Preparation method for therapeutic agent of bead-type chondrocyte

Inventors: Jung Sun Lee (Seoul, KR); Jin Yeon Lee (Gyeonggi-do, KR); Byung Chul Chae (Seoul, KR); Young Sook Son (Seoul, KR); Song Sun Chang (Seoul, KR)
Assignee: BIO SOLUTION CO., LTD.
A61K35/32A61K35/28C12N5/0062C12N5/0655C12N2500/90C12N2513/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,956,251
App. No.
14/901,635
Granted
May 1, 2018
Kind
B2
Abstract

The present invention relates to a preparation method for a therapeutic agent of a bead-type chondrocyte and, more specifically, to: a preparation method for a therapeutic agent of a bead-type chondrocyte without a support, comprising the steps of: a) dispensing chondrocytes and/or cells having chondrogenic differentiation capability in a 96-well deep well plate having a V-shaped bottom; b) centrifuging the plate; c) three-dimensionally culturing the plate in an incubator; and d) recovering pellets from each well, thereby being capable of easily and stably preparing cartilage tissues of a uniform quality, in large quantities; and a therapeutic agent of a bead-type chondrocyte without a support, prepared by the method, having effectiveness to repair damage by simply being implanted into cartilage damage by injection.

Claims (14)

1. A method for preparing a therapeutic agent of bead-type chondrocyte which comprises the following steps:

a) dispensing chondrocyte and/or cell having chondrogenic potential into a 96-well deep well plate having V-shaped bottom and well volume of 500 μl or more, with 0.5×10 5 cells to 2.0×10 5 cells/400 to 600 μl/well;

b) centrifuging the plate;

c) three-dimensionally culturing the plate in an incubator; and

d) collecting a pellet from each well.

2. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , wherein the cell having chondrogenic potential in step (a) is selected from the group consisting of mesenchymal stem cell, embryonic stem cell and induced pluripotent stem cell.

3. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 2 , wherein the mesenchymal stem cell is adipose-derived, bone marrow-derived, umbilical cord-derived, umbilical cord blood-derived, placenta-derived, synovium-derived, periosteum-derived or perichondrium-derived cell.

4. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , wherein said chondrocyte or cell is dispensed with 0.5×10 5 cells to 2.0×10 5 cells/400 μl/well in step (a).

5. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , wherein said chondrocyte or cell is dispensed by the use of an apparatus selected from the group consisting of a multi-channel pipette, a multi-pipette, a microplate washer and a microplate dispenser in step (a).

6. The method for preparing a therapeutic agent of bead-type according to claim 1 , wherein the centrifugation is carried out at 500 to 3,000 rpm for 5 to 10 minutes in step (b).

7. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , wherein the three-dimensional culture is carried out in a serum-free culture medium in step (c).

8. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , wherein the three-dimensional culture is carried out for 3 days to 30 days in step (c).

9. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 1 , which further comprises a step of exchanging a culture medium in step (c).

10. The method for preparing a therapeutic agent of bead-type chondrocyte according to claim 9 , wherein the exchange of culture medium is carried out by the use of an apparatus selected from the group consisting of a multi-channel pipette, a multi-pipette, a microplate washer and a microplate dispenser.

Assignments (2)
CHANGE OF NAME Recorded Sep 19, 2017
From: MCTTBIO CO., LTD.
To: BIO SOLUTION CO., LTD.
Reel/Frame 044403/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: LEE, JUNG SUN; LEE, JIN YEON; CHAE, BYUNG CHUL; SON, YOUNG SOOK; CHANG, SONG SUN
To: MCTT BIO INC.,
Reel/Frame 037370/0198 →
Priority Claims (1)
KR 10-2013-0087533 · Jul 24, 2013 · national
Continuity (1)
Related Publication 20160367601A1 · Dec 22, 2016